AAAAAA

   
Results: 1-20 |
Results: 20
CELLULITIS, EOSINOPHILIA, AND UNILATERAL PLEURAL EFFUSION ASSOCIATED WITH CLOZAPINE TREATMENT
Authors: CHATTERJEE A SAFFERMAN AZ
Citation: A. Chatterjee et Az. Safferman, CELLULITIS, EOSINOPHILIA, AND UNILATERAL PLEURAL EFFUSION ASSOCIATED WITH CLOZAPINE TREATMENT, Journal of clinical psychopharmacology, 17(3), 1997, pp. 232-233
DO WHITE-CELL COUNT SPIKES PREDICT AGRANULOCYTOSIS IN CLOZAPINE RECIPIENTS
Authors: ALVIR JMJ LIEBERMAN JA SAFFERMAN AZ
Citation: Jmj. Alvir et al., DO WHITE-CELL COUNT SPIKES PREDICT AGRANULOCYTOSIS IN CLOZAPINE RECIPIENTS, Psychopharmacology bulletin, 31(2), 1995, pp. 311-314
A COMPARISON OF EUROPEAN AND AMERICAN DOSING REGIMENS OF SCHIZOPHRENIC-PATIENTS ON CLOZAPINE - EFFICACY AND SIDE-EFFECTS
Authors: POLLACK S LIEBERMAN JA FLEISCHHACKER WW BORENSTEIN M SAFFERMAN AZ HUMMER M KURZ M
Citation: S. Pollack et al., A COMPARISON OF EUROPEAN AND AMERICAN DOSING REGIMENS OF SCHIZOPHRENIC-PATIENTS ON CLOZAPINE - EFFICACY AND SIDE-EFFECTS, Psychopharmacology bulletin, 31(2), 1995, pp. 315-320
CLOZAPINE AND NEW-ONSET ECG ABNORMALITIES
Authors: ARONOWITZ JS UMBRICHT DSG SAFFERMAN AZ
Citation: Js. Aronowitz et al., CLOZAPINE AND NEW-ONSET ECG ABNORMALITIES, Psychosomatics, 36(1), 1995, pp. 82-83
MANAGEMENT OF CLOZAPINE-INDUCED ENURESIS
Authors: ARONOWITZ JS SAFFERMAN AZ LIEBERMAN JA
Citation: Js. Aronowitz et al., MANAGEMENT OF CLOZAPINE-INDUCED ENURESIS, The American journal of psychiatry, 152(3), 1995, pp. 472-472
PLASMA CLOZAPINE LEVELS AND CLINICAL-RESPONSE FOR TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS
Authors: KRONIG MH MUNNE RA SZYMANSKI S SAFFERMAN AZ POLLACK S COOPER T KANE JM LIEBERMAN JA
Citation: Mh. Kronig et al., PLASMA CLOZAPINE LEVELS AND CLINICAL-RESPONSE FOR TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS, The American journal of psychiatry, 152(2), 1995, pp. 179-182
SYNCOPE ASSOCIATED WITH THE COMBINATION OF CLOZAPINE AND ENALAPRIL
Authors: ARONOWITZ JS CHAKOS MH SAFFERMAN AZ LIEBERMAN JA
Citation: Js. Aronowitz et al., SYNCOPE ASSOCIATED WITH THE COMBINATION OF CLOZAPINE AND ENALAPRIL, Journal of clinical psychopharmacology, 14(6), 1994, pp. 429-430
UNRELATED AGRANULOCYTOSIS IN A PATIENT TAKING CLOZAPINE - RESPONSE
Authors: SAFFERMAN AZ LIEBERMAN JA ZEMAN D SZYMANSKI S PISCIOTTA AV RAI K
Citation: Az. Safferman et al., UNRELATED AGRANULOCYTOSIS IN A PATIENT TAKING CLOZAPINE - RESPONSE, Journal of clinical psychopharmacology, 14(3), 1994, pp. 211-211
CLOZAPINE, NEGATIVE SYMPTOMS, AND EXTRAPYRAMIDAL SIDE-EFFECTS
Authors: KANE JM SAFFERMAN AZ POLLACK S JOHNS C SZYMANSKI S KRONIG M LIEBERMAN JA
Citation: Jm. Kane et al., CLOZAPINE, NEGATIVE SYMPTOMS, AND EXTRAPYRAMIDAL SIDE-EFFECTS, The Journal of clinical psychiatry, 55(9), 1994, pp. 74-77
CLOZAPINE DOSE IN THE UNITED-STATES AND EUROPE - IMPLICATIONS FOR THERAPEUTIC AND ADVERSE-EFFECTS
Authors: FLEISCHHACKER WW HUMMER M KURZ M KURZTHALER I LIEBERMAN JA POLLACK S SAFFERMAN AZ KANE JM
Citation: Ww. Fleischhacker et al., CLOZAPINE DOSE IN THE UNITED-STATES AND EUROPE - IMPLICATIONS FOR THERAPEUTIC AND ADVERSE-EFFECTS, The Journal of clinical psychiatry, 55(9), 1994, pp. 78-81
THE USE OF CLOZAPINE IN NEUROLOGIC DISORDERS
Authors: SAFFERMAN AZ KANE JM ARONOWITZ JS GORDON MF POLLACK S LIEBERMAN JA
Citation: Az. Safferman et al., THE USE OF CLOZAPINE IN NEUROLOGIC DISORDERS, The Journal of clinical psychiatry, 55(9), 1994, pp. 98-101
PREDICTORS OF RESPONSE TO CLOZAPINE
Authors: LIEBERMAN JA KANE JM SAFFERMAN AZ POLLACK S HOWARD A SZYMANSKI S MASIAR SJ KRONIG MH COOPER T NOVACENKO H
Citation: Ja. Lieberman et al., PREDICTORS OF RESPONSE TO CLOZAPINE, The Journal of clinical psychiatry, 55(9), 1994, pp. 126-128
CLINICAL EFFECTS OF CLOZAPINE IN CHRONIC-SCHIZOPHRENIA - RESPONSE TO TREATMENT AND PREDICTORS OF OUTCOME
Authors: LIEBERMAN JA SAFFERMAN AZ POLLACK S SZYMANSKI S JOHNS C HOWARD A KRONIG M BOOKSTEIN P KANE JM
Citation: Ja. Lieberman et al., CLINICAL EFFECTS OF CLOZAPINE IN CHRONIC-SCHIZOPHRENIA - RESPONSE TO TREATMENT AND PREDICTORS OF OUTCOME, The American journal of psychiatry, 151(12), 1994, pp. 1744-1752
FLUOXETINE FOR OBSESSIONAL SYMPTOMS IN SCHIZOPHRENIA
Authors: TEJERA CA MAYERHOFF DJ SAFFERMAN AZ RAMOSLORENZI JR
Citation: Ca. Tejera et al., FLUOXETINE FOR OBSESSIONAL SYMPTOMS IN SCHIZOPHRENIA, The American journal of psychiatry, 151(1), 1994, pp. 149-150
AKATHISIA AND CLOZAPINE TREATMENT
Authors: SAFFERMAN AZ LIEBERMAN JA POLLACK S KANE JM
Citation: Az. Safferman et al., AKATHISIA AND CLOZAPINE TREATMENT, Journal of clinical psychopharmacology, 13(4), 1993, pp. 286-287
UNRELATED AGRANULOCYTOSIS IN A PATIENT TAKING CLOZAPINE
Authors: SAFFERMAN AZ LIEBERMAN JA ZEMAN D SZYMANSKI S PISCIOTTA AV RAI K
Citation: Az. Safferman et al., UNRELATED AGRANULOCYTOSIS IN A PATIENT TAKING CLOZAPINE, Journal of clinical psychopharmacology, 13(3), 1993, pp. 218-219
DOES CLOZAPINE CAUSE TARDIVE-DYSKINESIA
Authors: KANE JM WOERNER MG POLLACK S SAFFERMAN AZ LIEBERMAN JA
Citation: Jm. Kane et al., DOES CLOZAPINE CAUSE TARDIVE-DYSKINESIA, The Journal of clinical psychiatry, 54(9), 1993, pp. 327-330
CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THEUNITED-STATES
Authors: ALVIR JMJ LIEBERMAN JA SAFFERMAN AZ SCHWIMMER JL SCHAAF JA
Citation: Jmj. Alvir et al., CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THEUNITED-STATES, The New England journal of medicine, 329(3), 1993, pp. 162-167
INCIDENCE AND RISK-FACTORS OF CLOZAPINE-INDUCED AGRANULOCYTOSIS
Authors: SAFFERMAN AZ LIEBERMAN JA ALVIR JM
Citation: Az. Safferman et al., INCIDENCE AND RISK-FACTORS OF CLOZAPINE-INDUCED AGRANULOCYTOSIS, Biological psychiatry, 33(6A), 1993, pp. 127-127
PREDICTORS OF RESPONSE TO CLOZAPINE IN CHRONIC-SCHIZOPHRENIA
Authors: SAFFERMAN AZ LIEBERMAN JA POLLACK S SZYMANSKI S MASIAR S JOHNS C
Citation: Az. Safferman et al., PREDICTORS OF RESPONSE TO CLOZAPINE IN CHRONIC-SCHIZOPHRENIA, Biological psychiatry, 33(6A), 1993, pp. 131-131
Risultati: 1-20 |